Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

March 17, 2017

IN RE INSYS THERAPEUTICS, INC. SECURITIES LITIGATION

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. March 04, 2019

    Insys Investors Seek Cert. In Fentanyl Stock Drop Suit

    Insys Therapeutics Inc. investors urged a New York federal judge Friday to certify their putative class action accusing the pharmaceutical company of overstating its opioid spray's financial strength, a move that sparked a stock downturn once the accounting problems were revealed.

4 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login